REPL

Replimune Group, Inc.
Data: 2026-01-30
$7.03
Price
-4.94%
Change
$14.7952
52W High
$2.68
52W Low

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Quick Stats
Jan 30, 2026

54.7

AI Score

HOLD

0.94

Volume Ratio

Feb 11, 2026

Next Earnings

11

+ve Days (30d)

19

-ve Days (30d)

REPL Stock Summary

Last updated Jan 30, 2026

REPL is currently trading at $7.03, positioned below its 200-day moving average of $7.87, suggesting bearish momentum. The stock has a 52-week range of $2.68 to $14.7952.

Technical Analysis: The 50-day moving average stands at $9.03, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 32.636, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.17, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates REPL at 54.7/100 with a HOLD recommendation.

REPL (Replimune Group, Inc.) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 32.636
CMF (20) -0.17
ROC (10) -3.699
ADX (14) 21.955
Indicator Value
MACD (12,26,9) -0.528
AROONOSC (14) -42.857
WILLAMS %R (14) -84.431
MFI (14) 33.006
REPL Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

REPL Price vs Max Options Open Interest
REPL Max Change In Options Open Interest

REPL Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

REPL Daily Out of Money Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

REPL Daily In the Money Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

REPL Most Active Options by Volume(near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Replimune Group, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

REPL Moving Averages Analysis

REPL (Replimune Group, Inc.) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 7.38
20 7.79
30 8.48
50 9.03
100 7.77
200 7.87

REPL Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 551.5 million
Earnings/Share ($) -3.47
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -3.368
EPS Estimate Next Year ($) -2.0625
WallStreet Target Price ($) 12.5714
Most Recent Quarter